Artificial Intelligence Individualized Risk Classifier in Multiple Myeloma
Authors:
- 10 April 2024
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (11) , 1207-1210
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Big data in basic and translational cancer researchNature Reviews Cancer, 2022
- Implications of MYC Rearrangements in Newly Diagnosed Multiple MyelomaClinical Cancer Research, 2020
- Multiple myeloma immunoglobulin lambda translocations portend poor prognosisNature Communications, 2019
- A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisLeukemia, 2018
- Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesLeukemia, 2017
- A gene expression signature for high-risk multiple myelomaLeukemia, 2012
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004
- A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experienceBritish Journal of Haematology, 2003
- Multiple Myeloma: How Did It Begin?Mayo Clinic Proceedings, 1994
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975